24 Hrs
Source:
المشهد العربي
EamiPIC Plans to Raise $156 Million
Immetry Therapeutics, supported by Nvidia, is seeking to raise approximately $159.4 million through an initial public offering (IPO) on the NASDAQ, with a projected market valuation of around $805.8 million at the top of the price range. The company aims to issue about 9.38 million shares priced between $15 and $17 each, with trading expected to begin under the ticker symbol "IAM" once all procedures are completed. The company's goal is to fund drug development and expand its operations in the biotechnology sector.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)